See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

Bio

Generated by
Topline AI
Steve Nelson is a seasoned business development professional with 20+ years of experience in molecular diagnostics, life sciences, and digital marketing. He has held various leadership positions, including Vice President of Business Development at Cepheid, Sr. Director of Business Development at Arcxis Biotechnologies, and VP of Life Science Solutions at Entigen Corporation. Steve has a strong track record of securing collaborations, licenses, and funding for his companies, and has expertise in digital marketing, SEO, and content strategy.

Experience

    • Vice President, Business Development
      • 2008 - 2015

      BUSINESS DEVELOPMENT ACCOMPLISHMENTS:►Secured multiple Phama collaborations including but not limited to Novartis, GSK, AZ/MedImmune, Cubist/Merck, Alios/J&J, The Medicine Company, Shionogi and Aridis Pharmaceuticals.►Secured Collaborative Development relationships and license rights with major Universities worldwide for development of Oncology and Infectious Disease assays and related technologies.►Established, directed and managed multiple collaborative relationships with Donor Organization to secure $5M -$20M in non-dilutive funding for developing Cepheid products (for MTB, HIV, HCV, Ebola and CT/NG) specifically for the Cepheid High Burden Developing Countries. This strategy effectively positioned Cepheid as the dominant Molecular Diagnostics platform in both Developing and Emerging markets worldwide. Effectively, raised the barrier to competition by negotiating an $11M buy-down of the MTB product with BMGF, USAID and UNITAID substantially increasing the adoption of the test (over 12mil tests per year) at a subsidized lower price point of $9.98/test. CORPORATE DEVELOPMENT ACCOMPLISHMENTS:►Identified and negotiated with potential distribution partners in international markets (China, India and Japan) as part of global strategy to complement a direct presence in these markets.

    • Sr. Dir of Business Development
      • 2006 - 2008

      Arcxis Biotechnologies was an early stage, venture backed start-up focused on delivering next generation molecular diagnostic solutions. As an early member of the management team, my primary Business Development responsibilities included, contract negotiations, lease negotiations, license negotiations, channel development and coordination of all intellectual property and trademarks. As Sr. Director of Business Development I worked closely with the President and CEO to develop and implement the companies strategic plan and present the company to the venture community.BUSINESS DEVELOPMENT ACCOMPLISHMENTS:►Negotiated in license relationships with commercial and academic suppliers for proprietary media, reagents and other intellectually property critical to the Lysix product development.►Initiated strategic collaborative relationships with key vendors, and academic institutions to accelerate product development activities.►Secured > $15M in venture funding for Arcxis Biotechnologies Inc.

    • Vice President Business Development
      • 2002 - 2006

      Argonaut Technologies was a public company delivering technologies for combinatorial chemistry, solid phase extraction and chemistry synthesis. Primary responsibilities included, strategic M&A planning and execution, contract negotiations, channel development and coordination of all intellectual property and trademarks. As VP of Business Development I also served as key member of Argonaut’s executive staff and primary liaison for all outside legal counsel.M & A ACCOMPLISHMENTS:► Divested non-strategic HPLC Business in 2003 to W. R. Grace for $2M. This business was originally acquired as part of the acquisition of Jones Chromatography Ltd. by Argonaut in 2002 for approx $18M.► Participated in all aspects of sale of Argonaut Technologies Inc. to Biotage AB. This transaction was completed in June of 2005 and valued in excess of $20M.CONTRACT NEGOTIATIONS:► Acquired exclusive license agreements to key technologies required for new Argonaut Products:CHANNEL DEVELOPMENT: ► Expanded Argonaut sales channels by initiating and negotiating reseller/OEM agreements, establishing standard distributor agreements and adding key channel partners.

    • PRE IPO COMPANIES
      • 1995 - 2002

      ENTIGEN CORPORATION: VP, Life Science SolutionsMOLECULAR DYNAMICS: Software Product Manager, Sales Manager, CLSM Product ManagerDISTINCTIONS: Top-grossing Sales Manager, Molecular Dynamics Certified in the “Product Development Process” Diploma in “Counselor Selling” Diploma “Effective Presentations Course” Diploma “Management Training Course”

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Biotechnology”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles